PharVision Advisers’s Travelzoo TZOO Stock Holding History

PharVision Advisers’s Portfolio TZOO Stock Details TZOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,189	Closed	-$149K	–	1018
2025 Q3	$149K	Buy	+15,189	New	+$163K	0.08%	575

Other funds holding TZOO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PharVision Advisers's TZOO Position: Q4 2025 in Review

PharVision Advisers sold out of Travelzoo (TZOO) in Q4 2025, closing a stake of 15,189 shares — an estimated $149K sold.

PharVision Advisers first reported a position in TZOO in Q3 2025 and held it in 1 quarter. The position peaked at $149K in Q3 2025. 83 funds tracked by Wall St. Rank hold TZOO as of Q4 2025.

PharVision Advisers reported no remaining Travelzoo position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 15,189 Travelzoo shares in Q4 2025, an estimated $149K.
PharVision Advisers first reported a position in Travelzoo in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Travelzoo position peaked at $149K in Q3 2025.
83 funds tracked by Wall St. Rank held Travelzoo as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.